<DOC>
	<DOCNO>NCT01439984</DOCNO>
	<brief_summary>The purpose study evaluate whether PED-1 effective Placebo treatment premature ejaculation .</brief_summary>
	<brief_title>Trial PED-1 Male Patients With Premature Ejaculation</brief_title>
	<detailed_description>This study evaluate whether PED-1 effective Placebo treatment premature ejaculation . The patient randomize allocated two treatment group placebo , PED-1 . The criterion Intravaginal Ejaculation Latency Time ( IELT ) enrollment &gt; =2 min least 75 % sexual intercourse . To diagnosis premature ejaculation , PEDT ( Premature Ejaculation Diagnosis Tool ) use . The patient undergone drug free baseline period take test drug 12 week .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<mesh_term>Clomipramine</mesh_term>
	<criteria>Informed consent subject partner Men 2065 age Stable monogamous relation least 6 mo Premature Ejaculation Diagnosis Tool ( PEDT ) 9 At least 6 mo premature ejaculation Hx IELT = &lt; 2 min &gt; = 75 % evaluable event 4 week screening period History medical psychiatric illness Erectile dysfunction ( &lt; 21 International Index Erectile FunctionErectile Function ( IIEFEF ) domain score ) form sexual dysfunction Partner sexual dysfunction Known hypersensitivity clomipramine contraindication clomipramine</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>PE</keyword>
	<keyword>IELT</keyword>
	<keyword>DCIT</keyword>
</DOC>